Table 2.
Site | Treatment | Active Responses | Inactive Responses |
---|---|---|---|
| |||
Bilateral MO | Vehicle | 434±74 | 71±29 |
Lidocaine | 131±44 | 29±12 | |
| |||
Bilateral mSTN | Vehicle | 597±116 | 106±33 |
Lidocaine | 500±176 | 100±52 | |
| |||
Asymmetric MO/mSTN | Vehicle | 398±104 | 66±50 |
Lidocaine | 302±143 | 21±14 | |
| |||
Unilateral MO | Lidocaine | 123±34 | 15±10 |